Co-Authors
This is a "connection" page, showing publications co-authored by Shiv Sarin and Masao Omata.
Connection Strength
1.582
-
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017 Jul; 11(4):317-370.
Score: 0.721
-
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19. Hepatol Int. 2020 Dec; 14(6):920-929.
Score: 0.228
-
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020 Sep; 14(5):690-700.
Score: 0.223
-
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int. 2019 Nov; 13(6):649-661.
Score: 0.211
-
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? Hepatol Int. 2019 Mar; 13(2):103-109.
Score: 0.200